The DOI matches its Crossref record, with a small difference in title or year; 29 of the 29 references it cites were found in a registry or an index.
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: Norepinephrine is currently recommended as the first-line vasopressor in septic shock; however, early vasopressin use has been proposed as an alternative. OBJECTIVE: To compare the effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock. DESIGN, SETTING, AND PARTICIPANTS: A factorial (2×2), double-blind, randomized clinical trial conducted in 18 general adult intensive care units in the United Kingdom between February 2013 and May 2015, enrolling adult patients who had septic shock requiring vasopressors despite fluid resuscitation within a maximum of 6 hours after the onset of shock. INTERVENTIONS: Patients were randomly allocated to vasopressin (titrated up to 0.06 U/min) and hydrocortisone (n = 101), vasopressin and placebo (n = 104), norepinephrine and hydrocortisone (n = 101), or norepinephrine and placebo (n = 103). MAIN OUTCOMES AND MEASURES: The primary outcome was kidney failure-free days during the 28-day period after randomization, measured as (1) the proportion of patients who never developed kidney failure and (2) median number of days alive and free of kidney failure for patients who did not survive, who experienced kidney failure, or both. Rates of renal replacement therapy, mortality, and serious adverse events were secondary outcomes. RESULTS: A total of 409 patients (median age, 66 years; men, 58.2%) were included in the study, with a median time to study drug administration of 3.5 hours after diagnosis of shock. The number of survivors who never developed kidney failure was 94 of 165 patients (57.0%) in the vasopressin group and 93 of 157 patients (59.2%) in the norepinephrine group (difference, -2.3% [95% CI, -13.0% to 8.5%]). The median number of kidney failure-free days for patients who did not survive, who experienced kidney failure, or both was 9 days (interquartile range [IQR], 1 to -24) in the vasopressin group and 13 days (IQR, 1 to -25) in the norepinephrine group (difference, -4 days [95% CI, -11 to 5]). There was less use of renal replacement therapy in the vasopressin group than in the norepinephrine group (25.4% for vasopressin vs 35.3% for norepinephrine; difference, -9.9% [95% CI, -19.3% to -0.6%]). There was no significant difference in mortality rates between groups. In total, 22 of 205 patients (10.7%) had a serious adverse event in the vasopressin group vs 17 of 204 patients (8.3%) in the norepinephrine group (difference, 2.5% [95% CI, -3.3% to 8.2%]). CONCLUSIONS AND RELEVANCE: Among adults with septic shock, the early use of vasopressin compared with norepinephrine did not improve the number of kidney failure-free days. Although these findings do not support the use of vasopressin to replace norepinephrine as initial treatment in this situation, the confidence interval included a potential clinically important benefit for vasopressin, and larger trials may be warranted to assess this further. TRIAL REGISTRATION: clinicaltrials.gov Identifier: ISRCTN 20769191.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution (277,279).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [279]
Experimental — accuracy not yet measuredIn the citing paper
“Although there was no difference with respect to kidney injury (RR 0.89; 95% CI 0.72–1.11), vasopressin use reduced the risk of RRT (RR 0.71; 95% CI 0.53–0.97) [354].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“There was no significant difference between the vasopressin and norepinephrine groups in 28-day mortality [30.9% vs 27.5%; RR 1.13 (95% CI 0.85–1.51).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“Several meta-analyses suggest decreased mortality in patients with a pressure- and volume-limited strategy for established ARDS [353, 354].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,046
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun‐Buisson, C., Beale, R. J., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,789
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R. P., Singer, M., Freivogel, K., Weiss, Y., Benbenishty, J. S., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,162
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Self-citationHigh versus low blood-pressure target in patients with septic shock.
Asfar, P., Meziani, F., Hamel, J.-F., Grelon, F., Megarbane, B., Anguel, N., Mira, J.-P., Dequin, P.-F., Gergaud, S., Weiss, N., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312173 · Cited by 1,239
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 723
Vasodilatory Shock in the ICU: Perils, Pitfalls and Therapeutic Options
Vallabhajosyula, S., Jentzer, J. C., & Khanna, A. K. (2018) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-319-73670-9_9 · Cited by 5
Shah, R. S., Wenger, R. K., Patel, P. A., Davis, S., Ha, B., Feinman, J. W., Patel, S. J., Pulton, D. A., Weiss, S. J., Restrepo-Cardenas, J., et al. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.01.058 · Cited by 5
Buckley, M. S., & MacLaren, R. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.06.016 · Cited by 5
Vasopressin Administration Is Associated With Rising Serum Lactate Levels in Patients With Sepsis
Severson, K., Ritter-Cox, L., Raffa, J. D., Celi, L. A., & Gordon, W. J. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618794925 · Cited by 5
Toward Increased Understanding of the Steroid Controversy in Septic Shock
Russell, J. A., & Sevransky, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004038 · Cited by 6
Was ist gesichert in der Therapie der Sepsis?
Stahl, K., Seeliger, B., David, S., & Schmidt, J. J. (2020) · Der Internist · doi:10.1007/s00108-020-00895-w · Cited by 5
Wu, Y., & Lauffenburger, J. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243149 · Cited by 5
Running from a Bear: How We Teach Vasopressors, Adrenoreceptors, and Shock
Manson, D. K., Dzierba, A. L., Seitz, K. M., & Brodie, D. (2023) · ATS Scholar · doi:10.34197/ats-scholar.2021-0132ht · Cited by 6
Pharmacologic Agents for the Treatment of Vasodilatory Shock
Knotzer, H., Poidinger, B., & Kleinsasser, A. T. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190704101907 · Cited by 5
When and how to use predictive biomarkers for corticosteroid treatment of septic shock
Russell, J. A. (2018) · Critical Care · doi:10.1186/s13054-018-2254-z · Cited by 5
What should clinicians know about the renal effect and the mechanism of action of levosimendan?
Honoré, P. M., Redant, S., Moorthamers, S., Préseau, T., Kaefer, K. M., Gutierrez, L. B., Attou, R., Gallerani, A., Boer, W., & Bels, D. D. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1986483 · Cited by 5
Personalized Approaches to Patients with Intra-Abdominal Infections
Sartelli, M., Coccolini, F., Labricciosa, F. M., Siquini, W., Pipitone, G., Palmieri, M., Sbacco, V., Vallicelli, C., Marmorale, C., & Catena, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217774 · Cited by 4
Effect of Vasopressors and Vasodilators on Kidney Medulla Oxygenation
Honoré, P. M., Blackman, S., Perriens, E., Oueslati, I., Al-Sammour, C., Bankier, D. V., Bendoumou, M., Ramos-Prieto, M., Bulpa, P., Robert, A., et al. (2024) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-23-00011 · Cited by 4
Application of norepinephrine in the treatment of septic shock: a meta-analysis
Xu, Q., Jin, Y., Fu, L., & Li, Y. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-024-03827-x · Cited by 5
Zhu, X., Xue, J., Maimaitituerxun, R., Liu, Y., Zhou, Q., Zhou, Q., Zhao, S., Xu, H., Xie, H. W., Dai, W., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-05515-x · Cited by 4
Timing and response to vasopressin in children in a paediatric intensive care unit
Gelbart, B., Veysey, A., Ramesh, S., Summers, P., Satkumaran, S., Schlapbach, L. J., & Duke, T. (2025) · Intensive Care Medicine – Paediatric and Neonatal · doi:10.1007/s44253-025-00110-4 · Cited by 4
Kim, K., Choi, H. S., Chung, S. P., & Kwon, W. Y. (2018) · Springer eBooks · doi:10.1007/978-981-10-5406-8_5 · Cited by 5
Kulesza, S., Gignac, L., Colvin, C. A., Boll, S., Giuliano, C. A., Haan, B. J., Allen, B., Perez, M. M., Allen, M., & Edwin, S. B. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2811 · Cited by 4
Behal, M. L., Flannery, A. H., & Miano, T. A. (2024) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxae134 · Cited by 4
Huh, J., Kwon, H., Park, H., Park, S. C., Yun, S. S., & Chae, M. S. (2024) · Medicina · doi:10.3390/medicina60071066 · Cited by 4
Thomas, J. L., McGee, K. C., Hossain, A., Perkins, G. D., Gordon, A. C., Young, D., McAuley, D., Singer, M., Lall, R., Kramarić, T., et al. (2025) · Intensive Care Medicine Experimental · doi:10.1186/s40635-024-00708-6 · Cited by 4
Self-citationDid the beneficial renal outcomes with vasopressin VANISH?
Sacha, G. L., Lam, S. W., & Bauer, S. R. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.10.59 · Cited by 4
Recchia, A., Cascella, M., Altamura, S., Borrelli, F., Nittis, N. D., Dibenedetto, E., Labonia, M., Pavone, G., & Gaudio, A. D. (2021) · Antibiotics · doi:10.3390/antibiotics10121526 · Cited by 4
Kumar, R., Chowdhury, J. B., & Jain, R. K. (2001) · PubMed · Cited by 4
The Perioperative Management of the Patient with Chronic Kidney Disease
Karambelkar, A. D., Chawla, L. S., & Busse, L. W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00079-6 · Cited by 4
Evidence for the Application of Sepsis Bundles in 2021
Plata-Menchaca, E. P., Ruiz‐Rodríguez, J. C., & Ferrer, R. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1733899 · Cited by 4
A Novel Role for Cytochrome P450 Epoxygenase Metabolites in Septic Shock
Jones, T. N., Janani, L., Gordon, A. C., Al-Beidh, F., & Antcliffe, D. B. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000622 · Cited by 4
Self-citationCombined Thoracic and Abdominal Organ Transplantation: Special Considerations
Yager, A., Khorsand, S., Chokshi, R., & Cheruku, S. (2019) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253219870631 · Cited by 4
Pharmacological modulation of cardiac function and control of blood vessel calibre
Bertram-Ralph, E., & Amare, M. (2021) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2021.07.026 · Cited by 3
Vasopressin: a review of clinical indications
Oliva, G., & Ulloa, N. A. (2025) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.24.351 · Cited by 3
Mortality time frame variability in septic shock clinical trials: A systematic review
Laserna, A., Cuenca, J. A., Martin, P., Fowler, C., Correa, J. E. B., Manjappachar, N. K., Fowler, C. S., Lopez-Olivo, M. A., Borges, M., Sprung, C. L., et al. (2025) · Medicina Intensiva · doi:10.1016/j.medine.2025.502172 · Cited by 4
CD121b-positive neutrophils predict immunosuppression in septic shock
Chen, J., Zhang, J., Chen, S., Qin, J., Hu, X., Xi, S., Zhang, L., Zhou, M., Zhou, Y., Fu, B., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565797 · Cited by 3
Peltan, I. D., Groat, D., Jacobs, J. R., Tillman, E. H., Brintz, B. J., Chauv, S., Beesley, S. J., Edwards, J. H., Arizmendez, N., Hirshberg, E. L., et al. (2025) · CHEST Critical Care · doi:10.1016/j.chstcc.2025.100178 · Cited by 3
Hemodynamic failure during sepsis: What clinicians and researchers must know
Léone, M., Russell, L., Cecconi, M., Khanna, A. K., Pirracchio, R., Bauer, M., & Rello, J. (2025) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2025.101602 · Cited by 4
Self-citationUnlocking norepinephrine potential innovations in formulation and smart systems
Kumar, S., Sanap, S. N., Vasoya, M., Pandey, P., Khopade, A. J., & Sawant, K. K. (2025) · Discover Pharmaceutical Sciences · doi:10.1007/s44395-025-00027-z · Cited by 3
Perioperative Vasopressor Management in Noncardiac Surgical Patients
Nguyen, M., Khanna, A. K., Legrand, M. M., & Joosten, A. (2025) · Anesthesiology · doi:10.1097/aln.0000000000005820 · Cited by 3
Li, J., Zhao, M., & He, Q. (2025) · BioData Mining · doi:10.1186/s13040-025-00514-0 · Cited by 3
Vasopressin in cardiogenic shock: pathophysiology, clinical evidence, and therapeutic perspectives
Filomia, S., Buono, M. G. D., Saponara, G., d’Aiello, A., Pedicino, D., Moroni, F., Abbate, A., & Sanna, T. (2026) · ESC Heart Failure · doi:10.1093/eschf/xvag053 · Cited by 3
Current status of immunomodulatory therapies in adult sepsis patients: where do we stand?
Papatheodosiou, D., Giamarellos‐Bourboulis, E. J., & Tsoukas, C. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2646192 · Cited by 3
Cardiovascular Subphenotypes in Sepsis
Chotalia, M., Ali, M., Chotalia, R., Patel, J. M., Parekh, D., & Bangash, M. N. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007159 · Cited by 3
Wu, J., Huang, M., Wang, Q., Ma, Y., & Jiang, L. (2019) · Hong Kong Journal of Emergency Medicine · doi:10.1177/1024907919833205 · Cited by 3
Zhang, Y., Zhang, Y., & Li, X. (2019) · European Geriatric Medicine · doi:10.1007/s41999-019-00229-6 · Cited by 3
Vernon-Elliot, J., Goradia, S., Bellomo, R., Lankadeva, Y. R., Burrell, L. M., & See, E. J. (2024) · Shock · doi:10.1097/shk.0000000000002515 · Cited by 3
Sepsis and Acute Kidney Injury: Epidemiology, Pathophysiology, Diagnosis, and Management
Alobaidi, R., & Bagshaw, S. M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-8628-6_10 · Cited by 3
Critical care essentials for pharmacy trainees and new clinical practitioners
Erstad, B. L., Kiser, T. H., & Bauer, S. R. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa417 · Cited by 4
Organ donor management: Eight common recommendations and actions that deserve reflection
Chamorro-Jambrina, C., Muñoz-Ramírez, M. R., Martínez-Melgar, J. L., & Pérez-Cornejo, M. S. (2017) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2017.01.008 · Cited by 3
Vasopressor Therapy in Septic Shock
Lopa, A. J., Bhattacharjee, S., Mishra, R. C., Ahmed, A., & Sinha, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88271-2.00011-0 · Cited by 3
Beneš, J., Kasperek, J., Smékalová, O., Tégl, V., Kletečka, J., & Zatloukal, J. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030486 · Cited by 3
Raza, H. A., Arshad, A., Ayaz, A., Raja, M. H. R., Gauhar, F., Khan, M., & Jamil, B. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000274 · Cited by 3
Epidemiology of Organ Failure Before and During COVID-19 Pandemic Surge Conditions
Brogan, J., Fazzari, M. J., Philips, K., Aasman, B., Mirhaji, P., & Gong, M. N. (2022) · American Journal of Critical Care · doi:10.4037/ajcc2022990 · Cited by 3
Vasopressor Therapy in the Intensive Care Unit
Li, F., & Wimer, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-77335-8_50 · Cited by 3
Terlipressin or norepinephrine in septic shock: do we have the answer?
Williams, M. D., & Russell, J. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.05.07 · Cited by 3
Bridging the Translational Gap: The Challenges of Novel Drug Development in Critical Care
Lambden, S., & Summers, C. (2017) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-319-51908-1_30 · Cited by 3
Reddi, B. A. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-43683-4_17 · Cited by 3
Attempting to define and refine vasopressin use in septic shock: the VANISH trial
Roy, A., & Dellinger, R. P. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.12.11 · Cited by 3
Buckley, C. T., Turner, B., Walsh, D., Garrett, M. J., & Ooka, V. (2019) · Hospital Pharmacy · doi:10.1177/0018578719867646 · Cited by 2
Acute kidney injury data collection in intensive care trials: hurdles and solutions
Kotani, Y., Landoni, G., Zarbock, A., & Bellomo, R. (2023) · Minerva Anestesiologica · doi:10.23736/s0375-9393.23.17505-5 · Cited by 2
Ten take-home messages on vasopressin use in critically ill patients
Ferrer, R., Castro, P., Lorencio, C., Monclou, J., Marcos, P., Ochagavía, A., Ruiz‐Rodríguez, J. C., Trenado, J., Villavicencio, C., Yébenes, J. C., et al. (2024) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2024.09.009 · Cited by 2
Reinert, J. P., Becker, K., & Ohlinger, M. J. (2025) · Journal of Pharmacy Technology · doi:10.1177/87551225251320873 · Cited by 3
Yang, J., Liujiao, Y., Zhang, X., Xiong, J., Wang, F., & Shen, F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323431 · Cited by 2
Bastida, C., Lugea, A. E., Fernández-Polo, A., Moreno, F. B., Cerezuela, M. M., Chiva, E. D., García, T. B., García, M. Á. A., González, I., Albanell‐Fernández, M., et al. (2025) · Farmacia Hospitalaria · doi:10.1016/j.farma.2025.05.009 · Cited by 4
Wisén, E., Pivodic, A., Skagervik, A., Rizell, M., Bown, L. S., Ricksten, S.-E., & Svennerholm, K. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.09.021 · Cited by 2
Wang, H., Liu, X., & Zhang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1669636 · Cited by 2
Management of post-resuscitation vasoplegic shock: targets, strategies and outcomes
Jendoubi, A., de Roux, Q., Cariou, A., Taccone, F. S., Ghaleh, B., Tissier, R., Kohlhauer, M., & Mongardon, N. (2025) · Critical Care · doi:10.1186/s13054-025-05794-w · Cited by 2
Ciardi, F., Magri, C., Rubino, A., & Vail, E. A. (2025) · JHLT Open · doi:10.1016/j.jhlto.2025.100474 · Cited by 2
The poikilothermic hypothesis of sepsis
Fan, R. R., & Gautron, L. (2026) · Critical Care · doi:10.1186/s13054-026-05879-0 · Cited by 2
From prediction to navigation for artificial intelligence in medicine
Nadkarni, G. N., McGreevy, J., Gavin, N. P., Freeman, R., Darrow, B. J., Stump, L. S., Reich, D. S., Kohane, I. S., & Sakhuja, A. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00756-7 · Cited by 2
Ahn, C., Lee, G. S., Kim, J. H., Ahn, S., Hwang, S. Y., Kim, S.-M., Kim, W. Y., Park, S. M., Choi, S.-H., Kwon, W. Y., et al. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106933 · Cited by 2
Kalamar, Ž., Landoni, G., Gorenjak, M., Cestar, I., Fluher, J., Horvat, M., Jerenec, K., Kit, B., Marinšek, M., Puklavec, N., et al. (2026) · Critical Care · doi:10.1186/s13054-026-06323-z · Cited by 2
Lessons from the ICU: Choosing the Right Vasopressor
Fiorini, F., Antcliffe, D. B., & Gordon, A. C. (2019) · Lessons from the ICU · doi:10.1007/978-3-319-69269-2_30 · Cited by 2
Self-citationPrise en charge de la nécrose tubulaire aiguë en 2020
Lafargue, M.-C., Aubert, S., Rabemiarason, N., Vilaine, É., Ébel, A., Dargelos, M., Couturier, A., Massy, Z. A., & Essig, M. (2021) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2020.11.002 · Cited by 2
Kupchik, N. (2021) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2021.05.001 · Cited by 2
Health-Related Quality of Life in the Spi ronolactone to R educe I CD T herapy (SPIRIT) Trial
Liberato, A. C. S., Raitt, M. H., Zarraga, I. G. E., MacMurdy, K. S., & Dougherty, C. M. (2021) · Clinical Nursing Research · doi:10.1177/10547738211036817 · Cited by 2
Agentes vasoactivos en sepsis: revisión crítica de la literatura
Correa, J. E. B., Carrillo, V. P., Rondón-Carvajal, J., & Laserna, A. (2023) · Universitas Médica · doi:10.11144/javeriana.umed64-2.seps · Cited by 2
Renal dysfunction in surgical patients
Booke, H., Zarbock, A., & Meersch, M. (2024) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001203 · Cited by 2
Innocenti, F., Palmieri, V., Grossi, G., Maddaluni, L., Scardia, A., & Pini, R. (2024) · Anesthesia Research · doi:10.3390/anesthres1020013 · Cited by 2
Ahn, S., Jin, B.-Y., Lee, S., Park, J.-H., Cho, H., Moon, S., Han, S. K., Choi, P. C., Lee, Y. H., Park, S. O., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-96857-z · Cited by 2
Vasoaktive Substanzen im septischen Schock – individualisierte Strategien
Lehner, G. F., Mayerhöfer, T., Perschinka, F., Benda, B., & Joannidis, M. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01272-x · Cited by 2
Xu, H., Mo, R., Liu, Y., Niu, H., Cai, X., & He, P. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325110 · Cited by 2
The Endocrine System in Sepsis
Heming, N., Sivanandamoorthy, S., Meng, P., & Annane, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-73506-1_5 · Cited by 2
ATS Core Curriculum 2020. Adult Critical Care Medicine
Çoruh, B., Pasnick, S., Acho, M., Bass, G. D., Baston, C. M., Card, M. E., de Moraes, A. G., Griffeth, V. E. M., Kanj, A., Leveno, M. J., et al. (2020) · ATS Scholar · doi:10.34197/ats-scholar.2020-0015re · Cited by 2
Year 2021 in review - Intensive care
Beneš, J., Chvojka, J., Karvunidis, T., Kletečka, J., Máca, J., Zatloukal, J., & Matějovič, M. (2022) · Anesteziologie a intenzivní medicína · doi:10.36290/aim.2021.060 · Cited by 2
Ji, J., & Brown, D. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-52993-8.00021-7 · Cited by 2
Adrenal Dysfunction Caused by a Critical Condition During Extracorporeal Membrane Oxygenation
Altshuler, N. Е., Губарев, К. К., Kutsy, M. B., & Popugayev, K. A. (2023) · Russian Sklifosovsky Journal Emergency Medical Care · doi:10.23934/2223-9022-2023-12-1-66-77 · Cited by 2
Fármacos vasoactivos en el tratamiento del shock séptico
Andaluz‐Ojeda, D., Cantón‐Bulnes, M. L., Richter, C. P., & Garnacho‐Montero, J. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.03.007 · Cited by 2
Raghunandan, V., & Saoji, A. A. (2024) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2024.08.013 · Cited by 2
Hydrocortisone and arginine vasopressin in post-resuscitation shock: the HYVAPRESS trial
Géri, G., Lascarrou, J.-B., Lévy, B., Asfar, P., Müller, G., Legriel, S., Ricôme, S., Cour, M., Klouche, K., Sauneuf, B., et al. (2025) · Resuscitation Plus · doi:10.1016/j.resplu.2025.100982 · Cited by 2
Vasopressin—Magic Bullet in Vasoplegia Syndrome After Cardiac Surgery?
Bolliger, D., & Erb, J. M. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.06.006 · Cited by 2
Inotropes and Vasoactive Agents: Differences Between Europe and the United States
Beersel, D. V., & Rex, S. (2019) · Current anesthesiology reports · doi:10.1007/s40140-019-00323-2 · Cited by 2
Choc septique réfractaire à la noradrénaline
Meresse, Z., Medam, S., Mathieu, C., & Léone, M. (2019) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2019.03.002 · Cited by 3
Síndrome vasopléjico en cirugía cardíaca
Crespo, M. E. S., Calderón, D. A. O., Gómez, C. A. B., & Realpe, R. R. R. (2020) · Revista Uruguaya de Cardiología · doi:10.29277/cardio.35.3.17 · Cited by 2
Patel, J. S., Hidalgo, D. C., Capistrano, I., Mancl, E. E., & Rech, M. A. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211048623 · Cited by 2
Yonekawa, K. E., Barreto, E. F., & Sutherland, S. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_126 · Cited by 2
Silverstein, D. C., & Hart, S. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-76469-8.00157-x · Cited by 2
Perioperative Renal Pharmacological Protection During Cardiovascular Surgery
Belletti, A., Licheri, M., & Bove, T. (2019) · Springer eBooks · doi:10.1007/978-3-319-94761-7_16 · Cited by 2
Angiotensin II for the emergency physician
Wallis, M., Chow, J. H., Winters, M. E., & McCurdy, M. T. (2020) · Emergency Medicine Journal · doi:10.1136/emermed-2019-209062 · Cited by 2
Vasopressin for Septic Shock in a Medical-Surgical Intensive Care Unit
Patel, A., Beauchesne, A., Bredenkamp, N., McGloin, R., Stabler, S. N., & Boyce, K. (2020) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v73i3.2999 · Cited by 2
Terlipressin as a first choice in septic shock—not yet
Rocha, D., Moreira, F. T., & Neto, A. S. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.03.49 · Cited by 2
Vasopressor use in septic shock: separating evidence, practice, and future directions
Fage, N., Chew, M. S., & Asfar, P. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08337-1 · Cited by 2
Vasodilatory shock: a review of pathophysiology and vasopressor therapy
Rheingold, C. G., & Silverstein, D. C. (2024) · Companion animal · doi:10.12968/coan.2023.0072 · Cited by 1
Metadata
- Authors
- Gordon, A. C., Mason, A. J., Thirunavukkarasu, N., Perkins, G. D., Cecconi, M., Cepkova, M., Pogson, D. G., Aya, H. D., Anjum, A., Frazier, G. J., Santhakumaran, S., Ashby, D., Brett, S. J., & for the VANISH Investigators
- Affiliations
- Imperial College London (GB)
- London School of Hygiene & Tropical Medicine (GB)
- University of Warwick (GB)
- National Health Service (GB)
- Corresponding author
- Gordon, Anthony C.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-08-02
- Volume
- 316
- Issue
- 5
- Pages
- 509
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2489536306
- Semantic Scholar
- 0a2e8f0595aed35457448e71c5f52e2cd0ccb618
- Cited by
- 728
- References
- 29
- Citations by year
- 2026: 77 · 2025: 114 · 2024: 82 · 2023: 69 · 2022: 59 · 2021: 61 · 2020: 67 · 2019: 83 · 2018: 62 · 2017: 40 · 2016: 12
- FWCI
- 61.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- University of Brighton Repository (University of Brighton) (publishedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Warwick Research Archive Portal (University of Warwick) (submittedVersion)
- Funders
- University of Portsmouth
- Intensive Care Foundation
- University Hospital Southampton NHS Foundation Trust
- National Institute for Health and Care Research (NF-SI-0514-10139, NIHR/CS/009/007, PB-PG-0610-22350)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Barts Health NHS Trust
- University Hospitals Coventry and Warwickshire NHS Trust
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- septic shock, vasopressin, norepinephrine, renal failure, acute kidney injury, vasopressor therapy, cortisol, renal replacement therapy, mortality, intensive care unit patients, fluid resuscitation, serious adverse events, 90-day outcomes
- MeSH terms
- Adult, Aged, Aged, 80 and over, Critical Care, Double-Blind Method, Drug Administration Schedule, Female, Fluid Therapy, United Kingdom, Humans, Hydrocortisone, Intensive Care Units, Male, Middle Aged, Norepinephrine, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Outcome, Renal Replacement Therapy, Renal Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
